Condition: Dental Restoration, Permanent · Dental Restorations · Endodontic Treatment · Sponsor: Septodont
The aim of this present study is to collect additional data for the post-marketing follow-up of Biodentine™ XP and measure long-term (up to 10 years) performance and safety of the biomaterial in all its indications.
This description comes directly from the study's public registry record.
Clinical Operations Medical Affairs Department · 1 49 76 70 00 · clinical-operations@septodont.com
Always discuss trial participation with your own doctor first.
| Queen Astrid Dental Practice | Kraainem, Belgium | Recruiting |
| UZ Leuven - University hospital | Leuven, Belgium | Recruiting |
| HCL Lyon | Lyon, France | Recruiting |
| Cabinet dentaire | Nantes, France | Recruiting |
| Cabinet dentaire | Paris, France | Recruiting |
| Hôpital Rotschild | Paris, France | Recruiting |
| Hôpital Pitié Salpêtrière | Paris, France | Recruiting |
| CHU Rennes | Rennes, France | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06955429